by admin | May 12, 2023 | News & Opinions
by Justin Jackson – Phys.org Researchers at Sana Biotechnology, Inc., in California, have made a significant breakthrough in realizing the promise of stem cell therapy: stem cells that do not trigger an immune response from an immunologically incompatible donor....
by admin | May 10, 2023 | News & Opinions
By Longeveron MIAMI, May 09, 2023 (GLOBE NEWSWIRE) — Longeveron Inc. (NASDAQ: LGVN) (“Longeveron” or “Company”), a clinical stage biotechnology company developing regenerative medicines for unmet medical needs, today announced new...
by admin | May 9, 2023 | News & Opinions
by Innovation Quarter Some things are worth traveling for. We drive the extra hour to one-of-a-kind restaurants, we cross state lines for best-in-class specialists and we travel days to experience unrivaled natural wonders. One day, there will be products that we have...
by admin | May 6, 2023 | News & Opinions
Aubrey de Grey explains why the time is right to be extremely ambitious and audacious when it comes to longevity research. By Eleanor Garth – Longevity.Technology August will see the second annual Longevity Summit take place in Dublin. Packed with keynote...
by admin | May 5, 2023 | News & Opinions
By Axiom Space First time bioprinted solid tissue constructs to be sent to the International Space Station and induced pluripotent stem cells to be manufactured in space. Microgravity allows researchers to study the behavior of cells and tissues in a unique...
by admin | May 4, 2023 | News & Opinions
by Cassie Tomlin – Cedars Sinai A first-of-its-kind stem cell therapy for ALS passes a critical safety benchmark, advancing the search to slow down, reverse and prevent the disease. In a parallel study, investigators are growing patient-derived stem cells to...
